PULMOCIDE LIMITED

06182024
Active United Kingdom

Research and experimental development on biotechnology

9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PULMOCIDE LIMITED

06182024

Research and experimental development on biotechnology

Founded 23 Mar 2007 Active United Kingdom 9 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 2 Jun 2026 Next due 30 Sept 2026 3 months remaining
Confirmation
Net assets £22M £9M 2024 year on year
Total assets £25M £5M 2024 year on year
Total Liabilities £4M £4M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for PULMOCIDE LIMITED (06182024), an active life sciences and medical technology company based in United Kingdom. Incorporated 23 Mar 2007. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£4.34M

Decreased by £3.83M (-47%)

Net Assets

£21.63M

Increased by £8.61M (+66%)

Total Liabilities

£3.66M

Decreased by £3.76M (-51%)

Turnover

N/A

Employees

9

Debt Ratio

14%

Decreased by 22 (-61%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (16)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2013Series A
Investor 2Nov 2013Series A, Series B, Series C
Investor 3Mar 2017Series B, Series C

Share Capital

Share Capital

Share allotments and capital structure

26 Allotments 234,936,791 Shares £6666.16m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Sept 20253,490,190£3.14m£0.9
19 Jun 202550,000£4k£0.075
18 Apr 2025306,250£23k£0.075
18 Apr 202570,303£6k£0.09
18 Apr 202523,017,711£20.72m£0.9

Officers

Officers

2 active 1 resigned
Status
Fiona Caroline MashDirectorBritishEngland5522 Sept 2020Active
Sabine Kohar DandiguianDirectorFrenchFrance6518 May 2021Active

Shareholders

Shareholders (72)

Jeito Slp
16.7%
40,154,504
Ip2ipo Portfolio (gp) Limited
6.3%
15,222,221

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

PULMOCIDE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
20 Jan 2026CapitalAllotment of shares (GBP 2,444,896.68) on 29 Sept 2025
29 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
7 Jul 2025IncorporationMemorandum Articles
7 Jul 2025ResolutionResolutions
2 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

20 Jan 2026 Capital

Allotment of shares (GBP 2,444,896.68) on 29 Sept 2025

29 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

7 Jul 2025 Incorporation

Memorandum Articles

7 Jul 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

2 weeks ago on 2 Jun 2026

Allotment of shares (GBP 2,444,896.68) on 29 Sept 2025

4 months ago on 20 Jan 2026

Annual accounts made up to 31 Dec 2024

10 months ago on 29 Jul 2025

Memorandum Articles

11 months ago on 7 Jul 2025

Resolutions

11 months ago on 7 Jul 2025